Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

54.7K
Overview
54.7K
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

1.4K
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
1.4K
Vaccines01:21

Vaccines

63
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
63
Cross-reactivity00:42

Cross-reactivity

34.1K
Overview
34.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved genome editing by an engineered CRISPR-Cas12a.

Nucleic acids research·2022
Same author

Pathogenic Leptospires Limit Dendritic Cell Activation Through Avoidance of TLR4 and TRIF Signaling.

Frontiers in immunology·2022
Same author

Role of the major determinant of polar flagellation FlhG in the endoflagella-containing spirochete Leptospira.

Molecular microbiology·2021
Same author

Identification of in vivo expressed proteins in live attenuated lipopolysaccharide mutant that mediates heterologous protection against Leptospira spp.

Veterinary microbiology·2021
Same author

Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization.

PLoS neglected tropical diseases·2021
Same author

Correction: Leptospiral LPS escapes mouse TLR4 internalization and TRIF-associated antimicrobial responses through O antigen and associated lipoproteins.

PLoS pathogens·2020

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance
06:05

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

2.1K

Vaccines against leptospirosis.

Ben Adler1

  • 1Department of Microbiology, Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton, VIC, 3800, Australia, Ben.Adler@monash.edu.

Current Topics in Microbiology and Immunology
|November 13, 2014
PubMed
Summary

Current leptospirosis vaccines, primarily killed whole-cell bacterins, offer limited serovar-specific immunity. Newer approaches using reverse vaccinology show promise but require rigorous validation to ensure efficacy against Leptospira infections.

More Related Videos

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

363
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
10:47

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

16.3K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance
06:05

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

2.1K
A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

363
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
10:47

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

16.3K

Area of Science:

  • Veterinary immunology
  • Bacteriology
  • Vaccine development

Background:

  • Leptospirosis vaccines, first developed in 1916 using killed whole-cell bacterins, are still the only licensed options.
  • Existing bacterin vaccines provide immunity restricted to specific Leptospira serovars based on lipopolysaccharide (LPS) antigen.
  • Current vaccines are limited in their protective breadth against diverse Leptospira serogroups.

Purpose of the Study:

  • To review the historical development and current limitations of leptospirosis vaccines.
  • To evaluate the potential of novel vaccine strategies, including reverse vaccinology, for improved leptospirosis control.
  • To highlight the need for robust validation of new vaccine candidates.

Main Methods:

  • Historical review of leptospirosis vaccine development and usage.
  • Analysis of vaccine-induced immunity related to lipopolysaccharide (LPS) antigens.
  • Assessment of reverse vaccinology approaches utilizing genomic data for vaccine design.

Main Results:

  • Bacterin vaccines, used since 1916, remain the only licensed vaccines for leptospirosis in humans and animals.
  • Immunity from current vaccines is serovar-specific, offering limited cross-protection.
  • Many claims of protection with recombinant proteins are invalidated by inadequate challenge models and statistical analysis.

Conclusions:

  • There is a need for broadly protective leptospirosis vaccines beyond current serovar-specific bacterins.
  • Reverse vaccinology offers a promising avenue for developing next-generation vaccines.
  • Rigorous validation of new vaccine candidates, including appropriate challenge models and statistical methods, is crucial.